Functional measurement of local proteolytic activity in living cells of invasive and non-invasive tumors

Journal of Cellular Physiology

Volumn 202, Issue 3, 2005, Pages 690-697

  Ludwig, Thomas ^a   Püttmann, Sylvia ^a   Bertram, Helga ^a   Tatenhorst, Lars ^a   Paulus, Werner ^a   Oberleithner, Hans ^a   Senner, Volker ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A;

ARTICLE; BRAIN TUMOR; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CELL CULTURE; CELL HETEROGENEITY; CELL MEMBRANE PERMEABILITY; ELECTRIC RESISTANCE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FLUORESCENCE MICROSCOPY; FUNCTIONAL ASSESSMENT; GLIOBLASTOMA; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MICROENVIRONMENT; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR CELL LINE; UTERINE CERVIX CARCINOMA;

ANIMALS; BIOLOGICAL ASSAY; BRAIN NEOPLASMS; ELECTRIC IMPEDANCE; EXTRACELLULAR MATRIX; FLUORESCENT DYES; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASMS; PEPTIDE HYDROLASES; TUMOR CELLS, CULTURED;

EID: 12944300276     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20168     Document Type: Article

References (23)

1. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85:683-693.
2. Chintala K, Tonn JC, Rao JS. 1999. Matrix metalloproteinases and their biological function in human gliomas. Int J Dev Neurosci 17:495-502.
3. Deryugina EI, Bourdon MA, Luo GX, Reisfeld RA, Strongin A. 1997. Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci 110(Pt 19):2473-2482.
4. Egeblad M, Werb Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174.
5. Forsyth PA, Laing TD, Gibson AW, Rewcastle NB, Brasher P, Sutherland G, Johnston RN, Edwards DR. 1998. High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma. J Neurooncol 36:21-29.
6. Gekle M, Wunsch S, Oberleithner H, Silbernagl S. 1994. Characterization of two MDCK-cell subtypes as a model system to study principal cell and intercalated cell properties. Pflugers Arch 428:157-162.
7. Gutwein P, Oleszewski M, Mechtersheimer S, Agmon-Levin N, Krauss K, Altevogt P. 2000. Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells. J Biol Chem 275:15490-15497.
8. Hu B, Guo P, Fang Q, Tao HQ, Wang D, Nagane M, Huang HJ, Gunji Y, Nishikawa R, Alitalo K, Cavenee WK, Cheng SY. 2003. Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2. Proc Natl Acad Sci USA 100:8904-8909.
9. Kleihues P, Cavenee WK. 2000. World health organisation classification of tumours. Pathology and genetics. Tumours of the nervous system. Lyon: WHO.
10. Ludwig T, Ossig R, Graessel S, Wilhelmi M, Oberleithner H, Schneider SW. 2002. The electrical resistance breakdown assay determines the role of proteinases in tumor cell invasion. Am J Physiol Renal Physiol 283:F319-F327.
11. Mikkelsen T, Yan PS, Ho KL, Sameni M, Sloane BF, Rosenblum ML. 1995. Immunolocalization of cathepsin B in human glioma: Implications for tumor invasion and angiogenesis. J Neurosurg 83:285-290.
12. Moss ML, Lambert MH. 2002. Shedding of membrane proteins by ADAM family proteases. Essays Biochem 38:141-153.
13. Nabeshima K, Inoue T, Shimao Y, Okada Y, Itoh Y, Seiki M, Koono M. 2000. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor. Cancer Res 60:3364-3369.
14. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. 1997. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272:2446-2451.
15. Rao JS. 2003. Molecular mechanisms of glioma invasiveness: The role of proteases. Nat Rev Cancer 3:489-501.
16. Rempel SA, Rosenblum ML, Mikkelsen T, Yan PS, Ellis KD, Golembieski WA, Sameni M, Rozhin J, Ziegler G, Sloane BF. 1994. Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 54:6027-6031.
17. Sato H, Seiki M. 1996. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem (Tokyo) 119:209-215.
18. Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao JS. 1996. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 14:35-42.
19. Schneider SW, Ludwig T, Tatenhorst L, Braune S, Oberleithner H, Senner V, Paulus W. 2004. Glioblastoma cells release factors that disrupt blood-brain barrier features. Acta Neuropathol (Berlin) 107:272-276.
20. Schweitzer T, Vince GH, Herbold C, Roosen K, Tonn JC. 2001. Extraneural metastases of primary brain tumors. J Neurooncol 53:107-114.
21. Sternlicht MD, Werb Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516.
22. Takano S, Tsuboi K, Matsumura A, Sato H, Nose T. 2001. Localization of gelatinase activities in glioma tissues by film in situ zymography. Brain Tumor Pathol 18:145-150.
23. Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, Rao VH, Tomonaga M, Nicolson GL, Rao JS. 1994. Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 54:3656-3661.